PANACEA BIOTEC LTD. - 531349 - Intimation Of Reduction Of Debt By Way Of Novation Of 74,300 Unrated, Unlisted,Redeemable, Non-Convertible Debentures (Ncds)
Please find enclosed copy of Intimation of reduction of debt by way of novation of 74,300 unrated, unlisted,redeemable, non-convertible debentures (NCDs)under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Panacea Biotec Ltd - 531349 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Panacea Biotec Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Panacea Biotec Ltd - 531349 - Voting Results Of Hon'Ble National Company Law Tribunal Convened Meeting Of The Equity Shareholders Of Panacea Biotec Limited Held On January 28, 2020
This is in continuation to our earlier letter dated 29.01.2020 intimating the proceedings of the NCLT convened meeting of equity shareholders of Panacea Biotec Limited ("Demerged Company") held on Tuesday, 28.01.2020, as required under Reg 44 of the SEBI LODR Regulations. We are now submitting the detailed results of remote e-voting and poll conducted at the said meeting. The Demerged Company has provided voting facility through (i) remote e-voting; and (ii) by way of poll through ballot papers at the venue of the meeting to its equity shareholders. Pursuant to Regulation 44(3) of the SEBI LODR Regulations read with amended Rule 20 of Companies (Management and Administration) Rules, 2015, the combined results of remote e-voting and poll conducted in respect of voting by the equity shareholders of Demerged Company along with the Scrutinizer's Report is enclosed herewith as Annexure - A. PANACEA BIOTEC LTD. - 531349 - Proceedings Of NCLT Convened Meetings Of Equity Shareholders And Unsecured Creditors Of Panacea Biotec Limited ('Demerged Company') Held On Tuesday, January 28, 2020 At 11:00 A.M. And 2:00 P.M. Respectively
Please find enclosed proceedings of NCLT convened meetings of equity shareholders and unsecured creditors of Panacea Biotec Limited held on Tuesday, January 28, 2020 at 11:00 a.m. and 2:00 p.m. respectively. Panacea Biotec Ltd - 531349 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd Panacea Biotec Ltd - 531349 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- VINOD GOELDesignation :- Company Secretary and Compliance Officer Panacea Biotec Ltd - 531349 - Shareholding for the Period Ended December 31, 2019
Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith details of Shares dematerialized during December, 2019 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participant) Regulations, 2018 for the quarter ended December 31, 2019 We are enclosing herewith a certificate dated January 04, 2020, issued by Skyline Financial Services Private Limited, Registrar and Transfer Agent of the Company, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2019. Panacea Biotec Ltd - 531349 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiaries of the Company from January 01, 2020 till completion of 48 hours from the announcement to the Stock Exchanges of the Unaudited financial results of the Company for the quarter ending December 31, 2019. The date of meeting of the Board of Directors to approve the Unaudited financial results of the Company for the quarter ending December 31, 2019 will be informed in due course.